Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
Get Insiders for : 
Eli Lilly & Co (LLY)  
$733.51 8.64 (1.19%) as of 4:30 Fri 4/26


Download
   
Exchange: New York Stock Exchange
Security Type: Common
Shares Out: 956,580,000
Market Cap: 701.66(B)
Last Volume: 2,008,266 Avg Vol: 3,289,637
52 Week Range: $390.35 - $792.28
Level I Sector: Health Care
Level II Sector: Drugs
Level III Sector: Drug Manufacturers - Major

Member Indexes:
    S&P COMPOSITE 1500     NYSE COMPOSITE
    S&P 500

Rankings:
     
Insider 3 Months    :   -
Insider 6 Months    :   -
Insider 3/6 Months :   -
Guru Rank Number :  720
Guru Rank Value     : 1.4
Guru Occurances    : 2

 

            6 Months   1 Year   2 Year  
 
Company Profile   Eli Lilly and Company discovers, develops, manufactures, and markets products in a single business segment: human pharmaceutical products. Co.'s products include: diabetes products, oncology products, immunology products, neuroscience products, and other therapies. Co.'s diabetes products include: Baqsimi®, Basaglar®, Humalog®, Humulin®, Jardiance®, Lyumjev®, Trajenta®, and Trulicity®. Co.'s oncology products include: Alimta®, Cyramza®, Erbitux®, Retevmo®, Tyvyt®, and Verzenio®. Co.'s immunology products include: Olumiant® and Taltz®. Co.'s neuroscience products include: Cymbalta®, Emgality®, Reyvow®, and Zyprexa®. Co.'s other therapies include: Bamlanivimab, Cialis®, and Forteo®.


 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 0 0 0 656
Total Buy Value $0 $0 $0 $199,549
Total People Bought 0 0 0 1
Total Buy Transactions 0 0 0 1
Total Shares Sold 644,570 871,420 3,176,506 6,211,418
Total Sell Value $465,524,857 $608,633,217 $2,147,483,647 $2,147,483,647
Total People Sold 2 2 5 6
Total Sell Transactions 8 14 47 89
End Date 2024-01-28 2023-10-27 2023-04-28 2022-04-28

   
Records found: 1437
  Page 2 of 58  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

  
3m +/-  
Form
   Jonsson Patrik EVP&Pres, LLY Dia&Obe, LLY USA   •       –      –    2024-02-12 4 A $737.26 $3,953,188 D/D 5,362 44,583     -
   Skovronsky Daniel EVP, CSO & Pres. LRL & LLY Imm   •       –      –    2024-02-12 4 A $737.26 $9,518,027 D/D 12,910 123,738     -
   Lilly Endowment Inc   –       –       •   2024-02-09 4 S $740.27 $152,753,428 D/D (206,257) 99,118,810 2%     
   Ricks David A President, Chair, and CEO   •       •      –    2024-02-08 4 GD $0.00 $0 D/D 956 440,858     -
   Lilly Endowment Inc   –       –       •   2024-02-08 4 S $740.06 $6,470,336 D/D (8,743) 99,325,067 1%     
   Norton Johna EVP, Global Quality   •       –      –    2024-02-01 4 D $645.61 $365,415 D/D (566) 30,816     -
   Norton Johna EVP, Global Quality   •       –      –    2024-02-01 4 OE $0.00 $0 D/D 1,268 31,382     -
   White Anne E. EVP & Pres, Lilly Neuroscience   •       –      –    2024-02-01 4 D $645.61 $1,190,505 D/D (1,844) 60,206     -
   White Anne E. EVP & Pres, Lilly Neuroscience   •       –      –    2024-02-01 4 OE $0.00 $0 D/D 4,124 62,050     -
   Hakim Anat EVP, GC & Secretary   •       –      –    2024-02-01 4 D $645.61 $1,269,915 D/D (1,967) 24,664     -
   Hakim Anat EVP, GC & Secretary   •       –      –    2024-02-01 4 OE $0.00 $0 D/D 4,442 26,631     -
   Jonsson Patrik EVP&Pres, LLY Dia&Obe, LLY USA   •       –      –    2024-02-01 4 D $645.61 $1,190,505 D/D (1,844) 39,221     -
   Jonsson Patrik EVP&Pres, LLY Dia&Obe, LLY USA   •       –      –    2024-02-01 4 OE $0.00 $0 D/D 4,124 41,065     -
   Van Naarden Jacob EVP & Pres., Loxo@Lilly   •       –      –    2024-02-01 4 D $645.61 $1,087,853 D/D (1,685) 13,778     -
   Van Naarden Jacob EVP & Pres., Loxo@Lilly   •       –      –    2024-02-01 4 OE $0.00 $0 D/D 3,618 15,463     -
   Skovronsky Daniel EVP, CSO & Pres. LRL & LLY Imm   •       –      –    2024-02-01 4 D $645.61 $2,862,635 D/D (4,434) 110,828     -
   Skovronsky Daniel EVP, CSO & Pres. LRL & LLY Imm   •       –      –    2024-02-01 4 OE $0.00 $0 D/D 9,941 115,262     -
   Ricks David A President, Chair, and CEO   •       •      –    2024-02-01 4 D $645.61 $8,547,876 D/D (13,240) 441,814     -
   Ricks David A President, Chair, and CEO   •       •      –    2024-02-01 4 OE $0.00 $0 D/D 29,611 455,054     -
   Yuffa Ilya EVP & President, LLY Intl   •       –      –    2024-02-01 4 D $645.61 $1,074,295 D/D (1,664) 15,012     -
   Yuffa Ilya EVP & President, LLY Intl   •       –      –    2024-02-01 4 OE $0.00 $0 D/D 3,702 16,676     -
   Lilly Endowment Inc   –       –       •   2024-01-31 4 S $645.28 $50,920,924 D/D (78,573) 99,333,810 -12%     
   Lilly Endowment Inc   –       –       •   2024-01-30 4 S $645.11 $49,175,200 D/D (76,215) 99,412,383 -12%     
   Lilly Endowment Inc   –       –       •   2024-01-29 4 S $645.07 $34,854,422 D/D (54,032) 99,488,598 -12%     
   Lilly Endowment Inc   –       –       •   2024-01-16 4 S $645.55 $761,806 D/D (1,180) 99,542,630 -14%     
  1437 Records found
  1  2  3  4  5  6  7  8  9  Next   
  Page 2 of 58
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us